Floatz logo

Theprubicin

Malignant Neoplasm

Cancer Institute and Hospital, Chinese Academy of Medical SciencesSmall moleculePhase 2Dormant
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
81/ 100

Competitive context

14 Active assets in the Malignant Neoplasm cohort.

Asset / SponsorPhaseRating
MEGESTROL ACETATE IMPURITY B
Sixth Affiliated Hospital, Sun Yat-sen University
Phase 3B
Nbm-Bmx
Novelwise Pharmaceutical Corporation
Phase 1/2B
TACROLIMUS
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Phase 2B
Ponatinib
Sameek Roychowdhury
Phase 2B
Ethiodized Oil
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2B

View all 20 →

Same molecule, other indications

Theprubicin is also rated in:

hepatocellular carcinomaDormant
BB
Indicative ·
71 / 100
View asset →
Transarterial ChemoembolizationDormant
BB
Indicative ·
66 / 100
View asset →
Colon Cancer Liver MetastasisDormant
BB
Indicative ·
66 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →